Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(23)00160-1/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=268172138&_hsenc=p2ANqtz--CEUl4BHsiO-qf300OQQ-I2f89yRotUjXT136EQbiBVtwXPdNYW8No1bkDqN9WNQXOQ29YFYos4jhYy4PWnaybfz-Ogw&utm_content=268146206&utm_source=hs_email